Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease

JAMA - Journal of the American Medical Association

Volumn 317, Issue 6, 2017, Pages 626-634

  Emdin, Connor A ^a,b   Khera, Amit V ^a,b   Natarajan, Pradeep ^a,b   Klarin, Derek ^a,b   Zekavat, Seyedeh M ^a,b   Hsiao, Allan J ^c   Kathiresan, Sekar ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BIOBANK; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC TRAIT; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC TRAIT; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHENOTYPE; POLYGENIC RISK SCORE; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; WAIST HIP RATIO; ANALYSIS; BLOOD; CORONARY ARTERY DISEASE; GENETICS; MIDDLE AGED; ODDS RATIO;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 85014708940     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.21042     Document Type: Article

References (32)

1. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med. 2012;9(5):e1001212.
2. Whitlock G, Lewington S, Sherliker P, et al; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-1096.
3. Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301-1313.
4. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. Br Med J (Clin Res Ed). 1985;290(6483):1692-1694.
5. Seidell JC, Björntorp P, Sjöström L, Sannerstedt R, Krotkiewski M, Kvist H. Regional distribution of muscle and fat mass in men-new insight into the risk of abdominal obesity using computed tomography. Int J Obes. 1989;13(3):289-303.
6. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Obesity and the risk ofmyocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640-1649.
7. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: ameta-analysis. Epidemiol Rev. 2007;29(1):115-128.
8. Han TS, Bijnen FC, Lean ME, Seidell JC. Separate associations of waist and hip circumference with lifestyle factors. Int J Epidemiol. 1998;27(3):422-430.
9. Smith GD, Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32 (1):1-22.
10. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304-314.
11. NikpayM, Goel A, Won HH, et al; CARDIoGRAMplusC4D Consortium. A comprehensive 1, 000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10): 1121-1130.
12. Pattaro C, Teumer A, Gorski M, et al; ICBP Consortium; AGEN Consortium; CARDIOGRAM; CHARGe-Heart Failure Group; ECHOGen Consortium. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun. 2016;7: 10023.
13. Morris AP, Voight BF, Teslovich TM, et al; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981-990.
14. Shungin D, Winkler TW, Croteau-Chonka DC, et al; ADIPOGen Consortium; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GEFOS Consortium; GENIE Consortium; GLGC; ICBP; International Endogene Consortium; LifeLines Cohort Study; MAGIC Investigators; MuTHER Consortium; PAGE Consortium; ReproGen Consortium. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518(7538):187-196.
15. Locke AE, Kahali B, Berndt SI, et al; LifeLines Cohort Study; ADIPOGen Consortium; AGEN-BMI Working Group; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; International Endogene Consortium. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.
16. Willer CJ, Schmidt EM, Sengupta S, et al; Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274-1283.
17. Scott RA, Lagou V, Welch RP, et al; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44(9):991-1005.
18. Stitziel NO, Stirrups KE, Masca NG, et al; Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators. Coding Variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N Engl J Med. 2016;374(12):1134-1144.
19. Ehret GB, Munroe PB, Rice KM, et al; International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM Consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen Consortium; CHARGE-HF Consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103-109.
20. MoffattMF, Gut IG, Demenais F, et al; GABRIEL Consortium. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211-1221.
21. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658-665.
22. Stock JH, Wright JH, Yogo M. A survey of weak instruments and weak identification in generalized method of moments. J Bus Econ Stat. 2002;20 (4):518-529.
23. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk ofmyocardial infarction: aMendelian randomisation study. Lancet. 2012;380(9841):572-580.
24. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909.
25. Burgess S, Davies NM, Thompson SG; EPIC-InterAct Consortium. Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology. 2014;25(6):877-885.
26. Do R, Willer CJ, Schmidt EM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45 (11):1345-1352.
27. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943): 626-635.
28. Gupta M, Singh N, Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation. 2006;113(25):e924-e929.
29. Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? the 1995 Ancel Keys Lecture. Circulation. 1997;95(1): 252-264.
30. Rodgers RJ, Tschöp MH, Wilding JPH. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012;5(5):621-626.
31. Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740-752.
32. von Hinke S, Davey Smith G, Lawlor DA, Propper C, Windmeijer F. Genetic markers as instrumental variables. J Health Econ. 2016;45:131-148.